Pharmaprom
↗Casablanca, Morocco
Pharmaprom is a Moroccan pharmaceutical company established in 2007, focused on the development, manufacturing, and distribution of generic pharmaceutical products. The company operates a modern production facility in Casablanca that complies with international Good Manufacturing Practices (GMP) standards, with an annual capacity exceeding 300 million units.
Strategically, Pharmaprom focuses on addressing unmet medical needs in the Moroccan market, particularly for serious pathologies. Their therapeutic portfolio includes oncology, gynecology, antibiotics, and contrast agents. The company actively collaborates with international laboratories to bring essential treatments to the Moroccan population at affordable prices.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:$1M-$5M
Founded:2007
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Various international laboratories (for technology transfer and product development)
COMPETITION
Position:Niche Player
Competitors:Cooper Pharma, Promamec, Hikma Pharmaceuticals (local operations)
LEADERSHIP
Key Executives:
Naoual Benyezzar - General Director
LINKS
Website:pharmaprom.ma
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Pharmaprom and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Pharmaprom. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.